SmileDirectClub (NASDAQ:SDC) Upgraded by Zacks Investment Research to Buy

Share on StockTwits

Zacks Investment Research upgraded shares of SmileDirectClub (NASDAQ:SDC) from a hold rating to a buy rating in a research note issued to investors on Tuesday morning, Zacks.com reports. They currently have $8.50 target price on the stock.

According to Zacks, “SmileDirectClub is in the oral care industry. Their clear-aligner treatment addresses the large global orthodontics market. “

Other research analysts also recently issued reports about the company. JPMorgan Chase & Co. reduced their target price on SmileDirectClub from $16.00 to $12.00 and set an overweight rating for the company in a research note on Thursday, May 14th. Jefferies Financial Group reissued a hold rating and issued a $6.50 price target on shares of SmileDirectClub in a report on Thursday, May 14th. Stephens started coverage on shares of SmileDirectClub in a report on Wednesday, June 24th. They set an overweight rating and a $11.00 price objective on the stock. ValuEngine upgraded shares of SmileDirectClub from a hold rating to a buy rating in a research report on Thursday, April 2nd. Finally, Bank of America downgraded shares of SmileDirectClub from a buy rating to an underperform rating and reduced their price target for the stock from $10.00 to $7.00 in a research report on Thursday, May 14th. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company’s stock. SmileDirectClub presently has an average rating of Buy and a consensus price target of $11.86.

SDC stock opened at $7.71 on Tuesday. The firm has a market cap of $2.89 billion and a PE ratio of -6.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 2.21 and a current ratio of 2.34. The firm’s fifty day moving average is $7.77 and its 200 day moving average is $8.32. SmileDirectClub has a one year low of $3.64 and a one year high of $21.10.

SmileDirectClub (NASDAQ:SDC) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($0.28) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.22) by ($0.06). The company had revenue of $196.65 million during the quarter, compared to analysts’ expectations of $205.64 million. Research analysts predict that SmileDirectClub will post -0.65 earnings per share for the current fiscal year.

In related news, insider Kay Oswald sold 10,000 shares of SmileDirectClub stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $10.04, for a total transaction of $100,400.00. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 66.04% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. State Street Corp purchased a new stake in shares of SmileDirectClub in the first quarter valued at about $174,000. Royal Bank of Canada grew its stake in shares of SmileDirectClub by 246.2% in the 1st quarter. Royal Bank of Canada now owns 51,763 shares of the company’s stock valued at $242,000 after buying an additional 36,811 shares during the period. Telemus Capital LLC increased its holdings in shares of SmileDirectClub by 70.9% during the 1st quarter. Telemus Capital LLC now owns 84,449 shares of the company’s stock worth $660,000 after buying an additional 35,024 shares during the last quarter. Morgan Stanley raised its position in shares of SmileDirectClub by 357.0% during the 1st quarter. Morgan Stanley now owns 1,289,976 shares of the company’s stock valued at $6,024,000 after buying an additional 1,007,685 shares during the period. Finally, Odey Asset Management Group Ltd purchased a new stake in shares of SmileDirectClub during the 1st quarter valued at approximately $1,074,000. 18.11% of the stock is currently owned by hedge funds and other institutional investors.

About SmileDirectClub

SmileDirectClub, Inc operates a teledentistry platform that provides member's with a customized clear aligner therapy treatment in the United States and internationally. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment proprietary with a network of approximately 240 state licensed orthodontists and general dentists through its teledentistry platform, SmileCheck.

Recommended Story: Stock Portfolio Tracker

Get a free copy of the Zacks research report on SmileDirectClub (SDC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for SmileDirectClub (NASDAQ:SDC)

Receive News & Ratings for SmileDirectClub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SmileDirectClub and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Invesco High Yield Equity Dividend Achievers ETF  Stock Rating Upgraded by TD Securities
Invesco High Yield Equity Dividend Achievers ETF Stock Rating Upgraded by TD Securities
Pacira Biosciences  Price Target Raised to $54.00
Pacira Biosciences Price Target Raised to $54.00
Oxford Square Capital  Upgraded to “Hold” by Zacks Investment Research
Oxford Square Capital Upgraded to “Hold” by Zacks Investment Research
Old Second Bancorp  Upgraded to Buy at Zacks Investment Research
Old Second Bancorp Upgraded to Buy at Zacks Investment Research
Osmotica Pharmaceuticals  Downgraded to Hold at Zacks Investment Research
Osmotica Pharmaceuticals Downgraded to Hold at Zacks Investment Research
$0.07 EPS Expected for PDC Energy Inc  This Quarter
$0.07 EPS Expected for PDC Energy Inc This Quarter


 
© 2006-2020 Zolmax.